Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

vTv Therapeutics Inc. (VTVT)

2.9   -0.04 (-1.36%) 02-14 16:00
Open: 2.99 Pre. Close: 2.94
High: 2.99 Low: 2.8
Volume: 512,456 Market Cap: 193M
vTv Therapeutics Inc is a biopharmaceutical company engaged in drug discovery and development. Its therapies are intended to treat diseases such as Alzheimer's and type-II diabetes. Its other products include TTP399, type II diabetes drug candidate.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.994 - 3.015 3.015 - 3.031
Low: 2.747 - 2.775 2.775 - 2.796
Close: 2.861 - 2.899 2.899 - 2.928

Technical analysis

as of: 2020-02-14 4:33:41 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 3.87     One year: 4.94
Support: Support1: 1.82    Support2: 1.51
Resistance: Resistance1: 3.31    Resistance2: 4.23
Pivot: 2.45
Moving Average: MA(5): 3.06     MA(20): 2.45
MA(100): 1.75     MA(250): 1.65
MACD: MACD(12,26): 0.25     Signal(9): 0.19
Stochastic oscillator: %K(14,3): 45.92     %D(3): 49.83
RSI: RSI(14): 63.61
52-week: High: 4.23  Low: 1.23  Change(%): 21.3
Average Vol(K): 3-Month: 75185  10-Days: 289770

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
VTVT has closed below upper band by 24.6%. Bollinger Bands are 293.4% wider than normal. The large width of the bands suggest high volatility as compared to VTVT's normal range. The bands have been in this wide range for 35 bars. This is a sign that the current trend might continue.

Headline News

The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 10) AbbVie Inc (NYSE: ABBV ) Allergan plc (NYSE: AGN ) )(reacted to better-than-expected results and comments that its deal to be acquired by AbbVie is on track to close by the first quarter) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Ascendis Pharma A/S (NASDAQ: ASND ) AtriCure Inc. (NASDAQ: ATRC ) ChemoCentryx Inc (NASDAQ: CCXI ) Co-Diagnostics Inc (NASDAQ: CODX )(announced sales of its new coronavirus test ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Insulet Corporation (NASDAQ: PODD ) Kodiak Sciences Inc (NASDAQ: KOD )(reacted to positive data readout from early-stage study of experimental drug to treat eye disorders) Masimo Corporation (NASDAQ: MASI ) Novartis AG (NYSE: NVS ) Pacira Biosciences Inc (NASDAQ: PCRX ) Principia Biopharma Inc (NASDAQ: PRNB ) PTC Therapeutics, Inc (NASDAQ: PTCT ) Revance Therapeutics Inc (NASDAQ: RVNC ) ResMed Inc.

VTV Therapeutics Shares Hit Multi-Year Highs After Diabetes Drug Aces Midphase Study
Shares of micro-cap biotech vTv Therapeutics Inc (NASDAQ: VTVT ) were advancing to their highest level since October 2018 Monday following a clinical readout … Full story available on

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 42.17
Shares Float (M) 8.84
% Held by Insiders 89.57
% Held by Institutions 1.75
Shares Short (K) 1250
Shares Short P. Month (K)

Stock Financials

EPS -0.584
Book Value (p.s.) -1.330
PEG Ratio
Profit Margin -133.76
Operating Margin -204.08
Return on Assets (ttm) -91.9
Return on Equity (ttm)
Qtrly Rev. Growth -99.8
Gross Profit (p.s.) -0.251
Sales Per Share
EBITDA (p.s.) -0.349
Qtrly Earnings Growth
Operating Cash Flow (M) -23.01
Levered Free Cash Flow (M) -17.14

Stock Valuations

P/E -4.97
P/E Growth Ratio -0.01
P/BV -2.18
P/S 10.00
P/CF -5.31

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.